Unknown

Dataset Information

0

Advances in targeted therapy for malignant lymphoma.


ABSTRACT: The incidence of lymphoma has gradually increased over previous decades, and it ranks among the ten most prevalent cancers worldwide. With the development of targeted therapeutic strategies, though a subset of lymphoma patients has become curable, the treatment of refractory and relapsed diseases remains challenging. Many efforts have been made to explore new targets and to develop corresponding therapies. In addition to novel antibodies targeting surface antigens and small molecular inhibitors targeting oncogenic signaling pathways and tumor suppressors, immune checkpoint inhibitors and chimeric antigen receptor T-cells have been rapidly developed to target the tumor microenvironment. Although these targeted agents have shown great success in treating lymphoma patients, adverse events should be noted. The selection of the most suitable candidates, optimal dosage, and effective combinations warrant further investigation. In this review, we systematically outlined the advances in targeted therapy for malignant lymphoma, providing a clinical rationale for mechanism-based lymphoma treatment in the era of precision medicine.

SUBMITTER: Wang L 

PROVIDER: S-EPMC7058622 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Advances in targeted therapy for malignant lymphoma.

Wang Li L   Qin Wei W   Huo Yu-Jia YJ   Li Xiao X   Shi Qing Q   Rasko John E J JEJ   Rasko John E J JEJ   Janin Anne A   Zhao Wei-Li WL  

Signal transduction and targeted therapy 20200306 1


The incidence of lymphoma has gradually increased over previous decades, and it ranks among the ten most prevalent cancers worldwide. With the development of targeted therapeutic strategies, though a subset of lymphoma patients has become curable, the treatment of refractory and relapsed diseases remains challenging. Many efforts have been made to explore new targets and to develop corresponding therapies. In addition to novel antibodies targeting surface antigens and small molecular inhibitors  ...[more]

Similar Datasets

| S-EPMC6770169 | biostudies-literature
| S-EPMC7369179 | biostudies-literature
| S-EPMC3003620 | biostudies-literature
| S-EPMC7683716 | biostudies-literature
| S-EPMC8350567 | biostudies-literature
| S-EPMC7542465 | biostudies-literature
| S-EPMC4293924 | biostudies-literature
| S-EPMC3638050 | biostudies-literature
| S-EPMC6927314 | biostudies-literature
| S-EPMC5801209 | biostudies-literature